Under the terms of the contract, Zargis will develop prototypes of a system designed to record, synchronize and analyse heart sounds, lung sounds and ECG signals in paediatric patients who are being cared for by remote military treatment facilities. The system will be fully integrated with an existing Army telehealth platform.
"We're very pleased that Zargis has been selected to enhance the Army's telehealth platform", stated Zargis CEO John Kallassy. "This project builds upon our expertise in computer-aided auscultation and we expect it to result in additional opportunities for Zargis involving military and civilian telemedicine initiatives."
Zargis Medical Corporation develops advanced diagnostic decision support products and services for primary care physicians, paediatricians, cardiologists and other health care professionals. Zargis was formed in 2001 when Siemens Corporate Research, a division of Siemens AG, and Speedus Corporation co-invested to develop and market an advanced acoustic technology designed to detect heart abnormalities identified through analysis of heart sounds.
Zargis has developed Cardioscan, the first and only computer-assisted medical device designed to support physicians in analysing heart sounds for the identification of suspected systolic and diastolic murmurs. Cardioscan is a non-invasive device that is easy to use, portable, and takes just minutes to perform. The device implements voice-guided protocol and a graphical user interface while maintaining an efficient physician work flow.
Cardioscan provides a summary of findings in terms that are readily understood by physicians and offers an additional range of quantitative auscultatory information that cannot be obtained through listening alone. As a result, Cardioscan enhances auscultation, a procedure that has been universally employed through a stethoscope for nearly two-hundred years.